Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot study

BACKGROUND: COVID-19 is a worldwide pandemic caused by the highly infective SARS-CoV-2. There is a need for biomarkers not only for overall prognosis but also for predicting the response to treatments and thus for improvements in the clinical management of patients with COVID-19. Circulating cell-fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoeter, Katharina, Neuberger, Elmo, Fischer, Susanne, Herbst, Manuel, Juškevičiūtė, Ema, Enders, Kira, Rossmann, Heidi, Sprinzl, Martin F., Simon, Perikles, Bodenstein, Marc, Schaefer, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2023
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512938/
https://www.ncbi.nlm.nih.gov/pubmed/37744227
http://dx.doi.org/10.7717/peerj.16072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512938/
https://www.ncbi.nlm.nih.gov/pubmed/37744227
http://dx.doi.org/10.7717/peerj.16072

Ejemplares similares